Hepatic Artery Chemoembolization for Hepatocellular Carcinoma in Patients Listed for Liver Transplantation

American Journal of Transplantation

Volumn 4, Issue 5, 2004, Pages 782-787

  Hayashi, Paul H ^a   Ludkowski, Michael ^a   Formana, Lisa M ^a   Osgood, Michael ^a   Johnson, Stephen ^a   Kugelmas, Marcelo ^a   Trotter, James F ^a   Bak, Thomas ^a   Wachs, Michael ^a   Kam, Igal ^a   Durham, Janette ^a   Everson, Gregory T ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Chemoembolization; Liver transplantation

Indexed keywords

CISPLATIN; DOXORUBICIN; IODINATED POPPYSEED OIL; MITOMYCIN;

ADULT; AGE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; FEMALE; HEPATIC ARTERY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK; TIME;

CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HEPATIC ARTERY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; SURVIVAL;

EID: 2442489095     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00413.x     Document Type: Article

References (19)

1. Sharma P, Balan V, Hernandez JL et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 2004; 10: 36-41.
2. Majno PE, Adam R, Bismuth H et al. Influence of preoperative transarterial lipiodol chemoembolization on the resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226: 688-703.
3. Roayaie S, Frisher JS, Emre SH et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 2002; 235: 533-539.
4. Oldhafer KJ, Chavan A, Fruhauf NR et al. Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit? J Hep 1998; 29: 953-959.
5. Llovet JM, Real MI, Montana X et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 2002; 359: 1734-1739.
6. Lo CM, Ngan H, Tso WK et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-1171.
7. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003; 37: 429-442.
8. Zhang Z, Liu Q, He J, Yang J, Yang G, Wu M. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Cancer 2000; 89: 2606-2612.
9. Di Carlo V, Ferrari G, Castoldi R et al. Pre-operative chemoembolization of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterol 1998; 45: 1950-1954.
10. Lu CD, Peng SY, Jiang XC, Chiba Y. Preoperative transcatheter arterial chemoembolization and prognosis of patients with hepatocellular carcinomas retrospective analysis of 120 cases. World J Surg 1999; 23: 293-300.
11. Yamasaki S, Hasegawa H, Kinoshita H et al. A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res 1996; 87: 206-211.
12. Spreafico C, Marchiano A, Regalia E et al. Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation. Radiology 1994; 192: 687-690.
13. Maluf DG, Fisher RA, Cotterell AH, Wolfe L, Shiffman ML, Posner MP. Non-resective ablation for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver waiting list [abstract]. Am J Transplant 2003; 3: 243.
14. Graziadei IW, Sandmueller H, Waldenberger P et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003; 9: 557-563.
15. Yao FY, Bass NM, Nikolai B et al. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy. Liver Transpl 2003; 9: 684-692.
16. Richard HM, Silberzweig JE, Mitty HA, Lou WY, Ahn J, Cooper JM. Hepatic arterial complications in liver transplant recipients treated with pretransplantation chemoembolization for hepatocellular carcinoma. Radiology 2000; 214: 775-779.
17. Liver Transplant Candidates with Hepatocellular Carcinoma. United Network for Organ Sharing OPTN/UNOS policy 3.6.4.4 2003 http://www.unos.org/frame_default.asp, accessed June 28.
18. Yao FY, Bass NM, Nikolai B et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transplant 2002; 8: 873-883.
19. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30: 1434-1440.